Impact Capital Partners LLC Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

Impact Capital Partners LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 6,299 shares of the healthcare conglomerate’s stock, valued at approximately $3,186,000. UnitedHealth Group makes up 1.1% of Impact Capital Partners LLC’s portfolio, making the stock its 18th largest position.

Several other institutional investors have also recently made changes to their positions in UNH. M&T Bank Corp lifted its position in shares of UnitedHealth Group by 13.4% in the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock worth $128,975,000 after buying an additional 26,074 shares in the last quarter. Sugarloaf Wealth Management LLC boosted its position in shares of UnitedHealth Group by 17.6% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after acquiring an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. increased its position in UnitedHealth Group by 1,275.3% in the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after purchasing an additional 41,308 shares during the last quarter. Parsifal Capital Management LP bought a new position in UnitedHealth Group during the third quarter valued at $21,165,000. Finally, Signal Advisors Wealth LLC raised its position in shares of UnitedHealth Group by 13.0% during the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after buying an additional 1,051 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on UNH. Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Oppenheimer increased their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Wells Fargo & Company cut their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Finally, KeyCorp restated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Stock Performance

UNH stock opened at $481.18 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market cap of $440.14 billion, a price-to-earnings ratio of 31.04, a PEG ratio of 1.37 and a beta of 0.62. The firm has a 50-day simple moving average of $512.33 and a two-hundred day simple moving average of $551.50. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the firm posted $5.83 earnings per share. The business’s quarterly revenue was up 6.8% on a year-over-year basis. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.75%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.